HAL vs IMRX
Halliburton Company (HAL) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the HAL and IMRX stock pages for the full models.
Not investment advice.